Elan Corporation plc
Related articles from Independent.ie
-
This could be worth upwards of €105m, depending on share price performance, based on the likely award structure.Elan...
-
...said yesterday.The company, which is best known for its multiple sclerosis drug Tysabri, should have the latest data for...
-
Future of controversial company is bright, but still hangs on approval of US regulator
Independent.ieThis is out of Elan's hands.The second choice is who can replace Mr Martin.Mr Martin
-
Ireland.GW Pharmaceuticals, the AIM-listed developer of the new treatment called Sativex, already sells the product...
-
The news of the fine came just three months after Elan announced in April 2010 that it was considering
Editor's Picks
There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.
-
Corporation, plc (ADR) (NYSE: ELN) looks really strong here, broke and closed above 50 day MA. Strong volume today! On the daily chart, we can see a few technical signals suggesting this swing higher in the short-term should continue a few more days. ... Full Article at Benzinga.com
-
Nevertheless, while Ingram says it's not Elan's strategy to sell the company, "if an offer comes in we can't ignore it." Against this backdrop, it looks like one options speculator is gambling on a significant rally for ELN within the next several months. Full Article at SchaeffersResearch.com: Daily Market Blog
-
Share price has risen to $14.23, a 7.9% increase. Share price rose over the last three months, now up $1.73 (13.8%) from $12.50 on February 29, 2012. The stock has moved up across its 50-day moving average of $13.53 today. Trading with a volume of... Full Article at FOX Business
-
7:55:40 AM Pharmaceuticals giant Elan could have a "path to market" for a new drug that would "transform" the company by the end of this year, the company said yesterday. The company, which is best known for its multiple sclerosis drug Tysabri, should... Full Article at Biospace
-
BOASTS the highest revenue per employee in the industry, chairman Bob Ingram told shareholders at the company’s annual general meeting in Dublin yesterday. Mr Ingram was addressing questions from shareholders about the progress of the company towards... Full Article at Irish Times
-
-
Elan Corporation, plc (“the Company”) announces that, at the Annual General Meeting held earlier today, all ordinary and special resolutions were duly passed. The full text of each resolution was included in the notice of the AGM dated 16 April 2012... Full Article at Business Wire
-
The Zacks Analyst Blog Highlights: Dr. Reddy's Laboratories, Bristol-Myers Squibb, Teva Pharmaceutical, Biogen Idec and Elan - Press Releases
Zacks Investment ResearchGrowth was mainly driven by new generic launches and was aided by an increase in the sales volume. However, in Europe, sales declined 2%, primarily due to exchange rate fluctuation and the pricing pressure in the German market. Biogen Idec (BIIB -... Full Article at Zacks Investment Research
-
The Zacks Consensus Estimate hinted at a loss of $0.15 per share. This was the second full quarter following the purchase of Elan Corporation 's ( ELN ) drug delivery unit, Elan Drug Technologies (EDT). We remind investors that Alkermes purchased the... Full Article at NASDAQ
About this topic
Wikipedia
There are no results for this module. Edit this module to change the search term used to query Wikipedia
Search Independent.ie topics
Related topics
Related videos
Related Conversations
Newsmap
See the geographical connection between Elan Corporation plc and different parts of the world. Mouse over the map pins to explore connections.
Sponsored Features
Highlights
Independentwoman.ie
Independent Woman
A fresh, fun site featuring celeb gossip, fashion, beauty, love & sex, and health & fitness.
- Independent Channels:
-
RSSLearn more...
-
MobileLearn more...
-
FacebookLearn more...
